Aurora Cannabis Inc (ACB) - Net Assets
Based on the latest financial reports, Aurora Cannabis Inc (ACB) has net assets worth $527.36 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($621.15 Million) and total liabilities ($93.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Aurora Cannabis Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $527.36 Million |
| % of Total Assets | 84.9% |
| Annual Growth Rate | 35.13% |
| 5-Year Change | -1.65% |
| 10-Year Change | 133.56% |
| Growth Volatility | 834.49 |
Aurora Cannabis Inc - Net Assets Trend (2007–2026)
This chart illustrates how Aurora Cannabis Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see ACB company net worth.
Annual Net Assets for Aurora Cannabis Inc (2007–2026)
The table below shows the annual net assets of Aurora Cannabis Inc from 2007 to 2026. Also explore net asset growth rate of Aurora Cannabis Inc to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | $513.15 Million | -15.19% |
| 2025-03-31 | $605.09 Million | +0.36% |
| 2024-03-31 | $602.92 Million | +15.56% |
| 2023-03-31 | $521.74 Million | 0.00% |
| 2022-03-31 | $521.74 Million | -74.36% |
| 2021-03-31 | $2.04 Billion | -3.74% |
| 2020-03-31 | $2.11 Billion | -51.99% |
| 2019-03-31 | $4.40 Billion | +181.67% |
| 2018-03-31 | $1.56 Billion | +611.66% |
| 2017-03-31 | $219.71 Million | +3728.85% |
| 2016-03-31 | $5.74 Million | +49.71% |
| 2015-03-31 | $3.83 Million | +182.05% |
| 2014-03-31 | $1.36 Million | +96.85% |
| 2013-03-31 | $690.35K | -36.08% |
| 2012-03-31 | $1.08 Million | -21.40% |
| 2011-03-31 | $1.37 Million | -19.72% |
| 2010-03-31 | $1.71 Million | +5.92% |
| 2009-03-31 | $1.62 Million | -3.97% |
| 2008-03-31 | $1.68 Million | 0.00% |
| 2007-03-31 | $1.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aurora Cannabis Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 645837983100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.03 Billion | 1369.05% |
| Other Comprehensive Income | $-214.15 Million | -41.73% |
| Other Components | $160.52 Million | 31.28% |
| Total Equity | $513.15 Million | 100.00% |
Aurora Cannabis Inc Competitors by Market Cap
The table below lists competitors of Aurora Cannabis Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Canaan Inc
NASDAQ:CAN
|
$236.25 Million |
|
Kalyani Investment Company Limited
NSE:KICL
|
$236.31 Million |
|
Spectral Med Inc
TO:EDT
|
$236.35 Million |
|
Lubelski Wegiel Bogdanka S.A.
WAR:LWB
|
$236.37 Million |
|
Eurobio Scientific SA
PA:ALERS
|
$236.10 Million |
|
Envipco Holding N.V.
AS:ENVI
|
$236.05 Million |
|
Chen Full International Co Ltd
TWO:8383
|
$235.99 Million |
|
Tian Zheng International Precision Machinery Co Ltd
TWO:6654
|
$235.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aurora Cannabis Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 563,911,753 to 513,154,708, a change of -50,757,045 (-9.0%).
- Net loss of 121,760,000 reduced equity.
- New share issuances of 10,906,000 increased equity.
- Other comprehensive income decreased equity by 158,231,155.
- Other factors increased equity by 218,328,110.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-121.76 Million | -23.73% |
| Share Issuances | $10.91 Million | +2.13% |
| Other Comprehensive Income | $-158.23 Million | -30.83% |
| Other Changes | $218.33 Million | +42.55% |
| Total Change | $- | -9.00% |
Book Value vs Market Value Analysis
This analysis compares Aurora Cannabis Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.48x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.04x to 0.48x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-03-31 | $103.34 | $4.27 | x |
| 2008-03-31 | $17.99 | $4.27 | x |
| 2009-03-31 | $13.47 | $4.27 | x |
| 2010-03-31 | $13.89 | $4.27 | x |
| 2011-03-31 | $10.38 | $4.27 | x |
| 2012-03-31 | $8.16 | $4.27 | x |
| 2013-03-31 | $5.17 | $4.27 | x |
| 2014-03-31 | $10.10 | $4.27 | x |
| 2015-03-31 | $0.60 | $4.27 | x |
| 2016-03-31 | $5.34 | $4.27 | x |
| 2017-03-31 | $94.49 | $4.27 | x |
| 2018-03-31 | $396.91 | $4.27 | x |
| 2019-03-31 | $549.12 | $4.27 | x |
| 2020-03-31 | $221.03 | $4.27 | x |
| 2021-03-31 | $120.34 | $4.27 | x |
| 2022-03-31 | $22.83 | $4.27 | x |
| 2023-03-31 | $15.20 | $4.27 | x |
| 2024-03-31 | $10.94 | $4.27 | x |
| 2025-03-31 | $10.11 | $4.27 | x |
| 2026-03-31 | $8.96 | $4.27 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aurora Cannabis Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -23.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -37.98%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.17x
- Recent ROE (-23.73%) is above the historical average (-63.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.08% | 0.00% | 0.00x | 1.00x | $-167.01K |
| 2008 | -10.54% | -340.87% | 0.03x | 1.00x | $-345.57K |
| 2009 | -9.01% | -356.71% | 0.03x | 1.01x | $-307.26K |
| 2010 | -2.57% | 0.00% | 0.00x | 1.01x | $-215.08K |
| 2011 | -23.47% | 0.00% | 0.00x | 1.01x | $-459.91K |
| 2012 | -29.24% | 0.00% | 0.00x | 1.07x | $-423.77K |
| 2013 | -57.00% | 0.00% | 0.00x | 1.04x | $-462.52K |
| 2014 | -29.41% | 0.00% | 0.00x | 1.39x | $-535.60K |
| 2015 | -248.34% | 0.00% | 0.00x | 3.53x | $-9.90 Million |
| 2016 | -99.73% | -397.71% | 0.08x | 3.19x | $-6.30 Million |
| 2017 | -5.90% | -71.78% | 0.06x | 1.47x | $-34.94 Million |
| 2018 | 4.61% | 130.33% | 0.03x | 1.22x | $-83.96 Million |
| 2019 | -6.67% | -119.54% | 0.04x | 1.28x | $-733.48 Million |
| 2020 | -153.50% | -1221.68% | 0.09x | 1.36x | $-3.50 Billion |
| 2021 | -34.08% | -282.82% | 0.09x | 1.34x | $-897.14 Million |
| 2022 | -354.46% | -785.77% | 0.24x | 1.89x | $-1.79 Billion |
| 2023 | -166.43% | -364.88% | 0.24x | 1.89x | $-865.69 Million |
| 2024 | -12.36% | -25.65% | 0.32x | 1.50x | $-125.40 Million |
| 2025 | 0.28% | 0.46% | 0.40x | 1.50x | $-54.80 Million |
| 2026 | -23.73% | -37.98% | 0.53x | 1.17x | $-173.08 Million |
Industry Comparison
This section compares Aurora Cannabis Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $260,984,185
- Average return on equity (ROE) among peers: -59.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $527.36 Million | 0.08% | 0.18x | $236.15 Million |
| ADC Therapeutics SA (ADCT) | $-185.83 Million | 0.00% | 0.00x | $143.73 Million |
| Akanda Corp (AKAN) | $26.90 Million | -43.34% | 0.45x | $1.65 Million |
| Akebia Ther (AKBA) | $74.01 Million | -330.87% | 6.15x | $262.52 Million |
| Alkermes Plc (ALKS) | $1.07 Billion | -10.39% | 0.83x | $7.26 Billion |
| Amylyx Pharmaceuticals Inc (AMLX) | $433.43 Million | 11.37% | 0.19x | $3.58 Billion |
| Amphastar P (AMPH) | $295.51 Million | -0.94% | 0.32x | $980.07 Million |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $346.79 Million | -104.36% | 9.57x | $5.92 Billion |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $208.93 Million | -62.22% | 17.18x | $3.57 Billion |
| Anika Therapeutics Inc (ANIK) | $82.14 Million | 4.49% | 0.59x | $279.44 Million |
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more